ELTX: Elicio Therapeutics, Inc. Stock

by  •  • Comments Off on ELTX: Elicio Therapeutics, Inc. Stock

SIC 2834 – Pharmaceutical Preparations

Valuation
Market Cap ($M) 93.01
Enterprise Value ($M) 80.12
Book Value ($M) 11.37
Book Value / Share 1.11
Price / Book 8.18
NCAV ($M) 0.57
NCAV / Share 0.06
Price / NCAV 161.76

Profitability (mra)
Return on Invested Capital (ROIC) -1.92
Return on Assets (ROA) -1.38
Return on Equity (ROE) -29.73

Liquidity (mrq)
Quick Ratio 1.67
Current Ratio 1.67

Balance Sheet (mrq) ($M)
Current Assets 16.35
Assets 27.15
Liabilities 15.77
Debt n/a
Equity n/a

Income Statement (mra) ($M)
Revenue 0.00
Operating Income -35.74
Net Income -35.20

Cash Flow Statement (mra) ($M)
Cash From Operations -32.69
Cash from Investing -0.03
Cash from Financing 38.61

(click for more detail)

File Date Form Activist 13D/G Investors Ownership
(%)		 Change
(%)
04-10 13D/A Clal Biotechnology Industries Ltd. 4.68 -19.60
03-20 13D/A Gkcc, Llc 19.99 6.41
07-07 13G/A Vifor (International) Ltd 0.02 -90.00
06-14 13D/A Angion Biomedica Corp. 3.70 -82.40

Top 13F Investors Shares
(1000)		 Change
(%)		 Value
($1000)		 Change
(%)

(click for more detail)

Date Insider Trades Code Shares Value

(click for more detail)

File Date Form SEC Filings
2024-03-29 10-K UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-K
2023-11-13 10-Q UNITED STATES SECURITIES AND EXCHANGE COMMISSION Washington, D.C. 20549 FORM 10-Q

(click for more detail)
Short Volume
Market Date Short Volume Total Volume Short Volume Ratio
2024-04-26 4,788 14,360 33.34
2024-04-25 1,481 4,392 33.72
2024-04-24 5,472 4,461 122.66
2024-04-23 1,277 8,401 15.20
2024-04-22 12,900 28,026 46.03

(click for more detail)

Similar Companies
CRVS – Corvus Pharmaceuticals, Inc. CVAC – CureVac N.V.
EGRX – Eagle Pharmaceuticals, Inc. ELYM – Eliem Therapeutics, Inc.
EOLS – Evolus, Inc.


Financial data and stock pages provided by
Fintel.io